Ludmila N Bakhireva1, Shikhar Shrestha2, Laura Garrison2, Lawrence Leeman3, William F Rayburn4, Julia M Stephen5. 1. Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, MSC09 5360, 1 University of New Mexico, Albuquerque, NM, 87131, USA; Department of Family and Community Medicine, School of Medicine, University of New Mexico, MSC09 5040, 1 University of New Mexico, Albuquerque, NM, 87131, USA. Electronic address: lbakhireva@salud.unm.edu. 2. Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, MSC09 5360, 1 University of New Mexico, Albuquerque, NM, 87131, USA. 3. Department of Family and Community Medicine, School of Medicine, University of New Mexico, MSC09 5040, 1 University of New Mexico, Albuquerque, NM, 87131, USA; Department of Obstetrics and Gynecology, School of Medicine, University of New Mexico, MSC10 5580, 1 University of New Mexico, Albuquerque, NM, 87131, USA. 4. Department of Obstetrics and Gynecology, School of Medicine, University of New Mexico, MSC10 5580, 1 University of New Mexico, Albuquerque, NM, 87131, USA. 5. The Mind Research Network, 1101 Yale Blvd. NE, Albuquerque, NM, 87106, USA; Lovelace Biomedical and Environmental Research Institute, 2425 Ridgecrest Dr. SE, Albuquerque, NM, 87108, USA.
Abstract
BACKGROUND: Prenatal care programs for women with opioid use disorder (OUD) often focus treatment/counseling plans around illicit substances, while concurrent use of alcohol might present an equal or greater risk to the fetus. METHODS: This study evaluated self-reported prevalence of alcohol use in patients participating in a comprehensive prenatal care program for women with substance use disorder (SUD; n = 295), of which 95% are treated for OUD, and pregnant women being served through general obstetrical clinics at the University of New Mexico (n = 365). During the screening phase of a prospective study, patients were asked to report alcohol use in the periconceptional period, and between the last menstrual period and pregnancy recognition. RESULTS: The screening interview was conducted at 22.3 (median = 22; Q1 = 16; Q3 = 29) gestational weeks. Among patients screened at the SUD clinic, 28.8% and 24.1% reported at least one binge drinking episode in the periconceptional period and in early pregnancy, respectively. The prevalence of binge drinking was similar in the general obstetrics population (24.7% and 24.4%, respectively). Among those who reported drinking in early pregnancy, median number of binge drinking episodes was higher among patients screened at the SUD clinic (median = 3; Q1 = 1; Q3 = 10) compared to the general obstetrics group (median = 1; Q1 = 1; Q3 = 3; p < 0.001). CONCLUSIONS: This study demonstrates a high prevalence of prenatal alcohol use in early pregnancy in both groups, while patients with SUD/OUD consume more alcohol. These findings underscore the need for targeted screening and intervention for alcohol use in all pregnant women, especially those with SUD/OUD.
BACKGROUND: Prenatal care programs for women with opioid use disorder (OUD) often focus treatment/counseling plans around illicit substances, while concurrent use of alcohol might present an equal or greater risk to the fetus. METHODS: This study evaluated self-reported prevalence of alcohol use in patients participating in a comprehensive prenatal care program for women with substance use disorder (SUD; n = 295), of which 95% are treated for OUD, and pregnant women being served through general obstetrical clinics at the University of New Mexico (n = 365). During the screening phase of a prospective study, patients were asked to report alcohol use in the periconceptional period, and between the last menstrual period and pregnancy recognition. RESULTS: The screening interview was conducted at 22.3 (median = 22; Q1 = 16; Q3 = 29) gestational weeks. Among patients screened at the SUD clinic, 28.8% and 24.1% reported at least one binge drinking episode in the periconceptional period and in early pregnancy, respectively. The prevalence of binge drinking was similar in the general obstetrics population (24.7% and 24.4%, respectively). Among those who reported drinking in early pregnancy, median number of binge drinking episodes was higher among patients screened at the SUD clinic (median = 3; Q1 = 1; Q3 = 10) compared to the general obstetrics group (median = 1; Q1 = 1; Q3 = 3; p < 0.001). CONCLUSIONS: This study demonstrates a high prevalence of prenatal alcohol use in early pregnancy in both groups, while patients with SUD/OUD consume more alcohol. These findings underscore the need for targeted screening and intervention for alcohol use in all pregnant women, especially those with SUD/OUD.
Authors: Kimberly Page; Cristina Murray-Krezan; Lawrence Leeman; Mary Carmody; Julia M Stephen; Ludmila N Bakhireva Journal: Addict Sci Clin Pract Date: 2022-01-06
Authors: Ludmila N Bakhireva; Lawrence Leeman; Melissa Roberts; Dominique E Rodriguez; Sandra W Jacobson Journal: Alcohol Clin Exp Res Date: 2021-02-02 Impact factor: 3.455
Authors: Kriti D Gandhi; Kathryn M Schak; Jennifer L Vande; Julia Shekunov; Brian A Lynch; Teresa A Rummans; Jennifer R Geske; Eric R Pease; Mara G Limbeck; Jinal Desai; Paul E Croarkin; Magdalena Romanowicz Journal: Prim Care Companion CNS Disord Date: 2021-06-10
Authors: Stephanie L Merhar; Julia E Kline; Adebayo Braimah; Beth M Kline-Fath; Jean A Tkach; Mekibib Altaye; Lili He; Nehal A Parikh Journal: Pediatr Res Date: 2020-11-11 Impact factor: 3.756